CYTOKINETICS

MU:KK3A Germany Other
Market Cap
$522.93K
€509.45K EUR
Market Cap Rank
#37445 Global
#4826 in Germany
Share Price
€54.85
Change (1 day)
+0.00%
52-Week Range
€26.80 - €58.50
All Time High
€92.00
About

CYTOKINETICS operates in Diversified Metals & Mining.

CYTOKINETICS (KK3A) - Net Assets

Latest net assets as of September 2024: €-13.91 Million EUR

Based on the latest financial reports, CYTOKINETICS (KK3A) has net assets worth €-13.91 Million EUR as of September 2024.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€1.44 Billion) and total liabilities (€1.45 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets €-13.91 Million
% of Total Assets -0.97%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 99.67

CYTOKINETICS - Net Assets Trend (2016–2023)

This chart illustrates how CYTOKINETICS's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for CYTOKINETICS (2016–2023)

The table below shows the annual net assets of CYTOKINETICS from 2016 to 2023.

Year Net Assets Change
2023-12-31 €-386.32 Million -258.04%
2022-12-31 €-107.90 Million -144.25%
2021-12-31 €243.86 Million +115.08%
2020-12-31 €113.38 Million +1136.69%
2019-12-31 €-10.94 Million -142.17%
2018-12-31 €25.93 Million -76.39%
2017-12-31 €109.84 Million +16.41%
2016-12-31 €94.36 Million --

Equity Component Analysis

This analysis shows how different components contribute to CYTOKINETICS's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 159394700000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2023)

Component Amount Percentage
Other Components €1.73 Billion %
Total Equity €-386.32 Million 100.00%

CYTOKINETICS Competitors by Market Cap

The table below lists competitors of CYTOKINETICS ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in CYTOKINETICS's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2022 to 2023, total equity changed from -107,900,000 to -386,323,000, a change of -278,423,000.
  • Net loss of 526,244,000 reduced equity.
  • New share issuances of 164,233,000 increased equity.
  • Other factors increased equity by 83,588,000.

Equity Change Factors (2022 to 2023)

Factor Impact Contribution
Net Income €-526.24 Million -136.22%
Share Issuances €164.23 Million +42.51%
Other Changes €83.59 Million +21.64%
Total Change €- %

Book Value vs Market Value Analysis

This analysis compares CYTOKINETICS's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €2.04 €54.85 x
2018-12-31 €0.47 €54.85 x
2019-12-31 €-0.18 €54.85 x
2020-12-31 €1.60 €54.85 x
2021-12-31 €2.88 €54.85 x
2022-12-31 €-1.14 €54.85 x
2023-12-31 €-3.80 €54.85 x

Capital Efficiency Dashboard

This dashboard shows how efficiently CYTOKINETICS utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -6988.63%
  • • Asset Turnover: 0.01x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-88.66%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 17.44% 15.46% 0.63x 1.80x €7.02 Million
2017 -116.34% -955.94% 0.05x 2.68x €-138.77 Million
2018 -409.84% -337.41% 0.15x 8.14x €-108.88 Million
2019 0.00% -452.93% 0.09x 0.00x €-120.60 Million
2020 -112.27% -228.00% 0.10x 4.71x €-138.63 Million
2021 -88.29% -305.72% 0.08x 3.45x €-239.70 Million
2022 0.00% -411.21% 0.09x 0.00x €-378.17 Million
2023 0.00% -6988.63% 0.01x 0.00x €-487.61 Million

Industry Comparison

This section compares CYTOKINETICS's net assets metrics with peer companies in the Other industry.

Industry Context

  • Industry: Other
  • Average net assets among peers: $114,212,818,724
  • Average return on equity (ROE) among peers: -9.08%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
CYTOKINETICS (KK3A) €-13.91 Million 17.44% N/A $515.95K
HORIBA (01H) $204.49 Billion 10.42% 0.82x $989.01K
Tokyu Corporation (01T) $779.37 Billion 3.34% 2.35x $99.73K
GUANGZHOU AUTO -H- (02G) $122.28 Billion 6.59% 0.55x $4.05K
MOSAIC (02M) $10.60 Billion 4.43% 0.90x $280.83K
MOSAIC (02M.SG) (02M) $9.56 Billion 10.46% 0.82x $247.21K
CHINA JO-JO DRGSTRS (04CN.SG) (04CN) $16.67 Million -126.83% 4.46x $1.55 Million
KRAKATAU STEEL -B- (07K) $552.59 Million 3.52% 4.72x $166.99
CN MODERN DAIRY (07M) $7.12 Billion -10.42% 1.50x $1.68K
TOURMALINE OIL (08T) $7.22 Billion 4.81% 0.41x $381.02K
ASIA CASSAVA RESOUR (0ACS) $913.15 Million 2.86% 1.55x $325.03